September 15, 2014
No Cognitive Disadvantage in Pediatric- vs Adult-Onset MS
- /
Sept 11, 2014 BOSTON — A new study suggests no cognitive disadvantage in the long term for patients with multiple…
MS Views and News, empowers those affected by Multiple Sclerosis (MS) with educational information, resources and services. Please scroll downward to find articles or videos of interest, then click to open the document or video.
September 15, 2014
Working Memory and Cognitive Reserve Linked in MS Kessler Foundation Study
- /
Any intervention that could help multiple sclerosis patients preserve long-term memory would likely be well-received. As suggested by a recent study from…
September 15, 2014
Plegridy Maintains Efficacy in Relapsing Multiple Sclerosis Trial
- /
- /
September 11, 2014 Biogen Idec announced new data from the second year of its Phase 3 ADVANCE clinical trial for Plegridy (peginterferon beta-1a),…
September 15, 2014
Tecifdera Efficacious for Relapsing-Remitting Multiple Sclerosis
- /
- /
Biogen Idec announced five-year results from the ENDORSE Phase 3 extension study with Tecfidera(dimethyl fumarate) in patients with relapsing-remitting multiple sclerosis (RRMS). ENDORSE is…
September 15, 2014
Mind, matter and multiple sclerosis
- /
Confusion, agitation, panic can flood a person attempting a simple task By Chase Olivarius-McAllister Herald Staff Writer Have you seen…
September 15, 2014
Undiagnosed sleep disorders common with MS
- /
The fatigue many people with multiple sclerosis (MS) experience may actually be a sign of an undiagnosed sleep disorder, according…
September 15, 2014
Sanofi Reports Data on Multiple Sclerosis Drug Lemtrada
- /
Pipeline updates are highly awaited events in the pharma/biotech sector as they play an important role in deciding whether or…
September 15, 2014
Why Inflammatory Bowel Disease Is Like Multiple Sclerosis
- /
By Deborah Mitchell G+ 2014-09-10 08:00 Inflammatory bowel disease and multiple sclerosis may seem worlds apart, but a new study points out…
September 15, 2014
Biogen Reports Positive Two-Year Data on MS Drug Plegridy – Analyst Blog
- /
Biogen Idec Inc. ( BIIB ) announced encouraging two-year data from the phase III ADVANCE study which evaluated the efficacy, safety and tolerability…
September 15, 2014
Teriflunomide (AUBAGIO) Is Now the First Oral Regimen Proven to Delay Onset of Clinically Definite Multiple Sclerosis
- /
Author: Michael R. Page, PharmD, RPh In a recent phase III trial published on September 2, 2014, in the journal Lancet…
